The differential regulation of PD-L1 and PD-L2 by cytokine signals indicates potential for molecular targeting and modulation of signaling pathways specific to either PD-L1 or PD-L2 in the context of cancer treatment, autoimmunity, or transplant tolerance. This evidence concerns the gene CD274 and cancer.